| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OSH | Common Stock, $0.001 par value | Sale | -$228,451 | -7,651 | -1.6% | $29.86 | 469,468 | 12 Jan 2023 | Direct | F1, F2 |
| transaction | OSH | Common Stock, $0.001 par value | Sale | -$18,022 | -599 | -0.13% | $30.09 | 468,869 | 12 Jan 2023 | Direct | F1, F3, F4 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. |
| F2 | The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.07 to $30.06, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (2). |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.07 to $30.10, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (3). |
| F4 | The Reporting Person's previous section 16 filings contained a scrivener's error that caused the number of shares of common stock owned directly by the reporting person to be overstated by 2,048 amount of shares. The Reporting Person has corrected that error in this filing. |